North America Closed Systems Drug Transfer Devices Market

Market Introduction

The closed system drug transfer devices provide protection against hazardous drugs or vapors during drug preparation and administration. It comprises components which enables filtering of dangerous vapors out of the system. Closed system drug transfer devices play a major role in protection of healthcare professionals from antineoplastic as well as other harmful medications.

North America Closed Systems Drug Transfer Devices Strategic Insights

Strategic insights for the North America Closed Systems Drug Transfer Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Closed Systems Drug Transfer Devices Report Scope

North America Closed Systems Drug Transfer Devices Regional Insights

The geographic scope of the North America Closed Systems Drug Transfer Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The North America closed systems drug transfer devices market is expected to reach US$ 648.78 million by 2027 from US$ 143.59 million in 2019. The market is anticipated to grow at a CAGR of 20.8% during 2019–2027. The growing adoption of chemotherapy and improvement of regulatory guidelines regarding hazardous drugs are the major factors expected to boost the growth of the closed systems drug transfer devices market in North America. However, the market is likely to get impacted by the risk factor such as stringent regulatory scenario and product safety issues during the forecast period.

Key Market Segments

In terms of closing mechanism, the push-to-turn systems segment accounted for the largest share of the North America closed systems drug transfer devices market in 2019. In terms of type, membrane-to-membrane systems segment accounted for the largest share of the North America closed systems drug transfer devices market in 2019. In terms of technology, the diaphragm-based devices segment accounted for the largest share of the North America closed systems drug transfer devices market in 2019. In terms of component, the vial access devices segment accounted for the largest share of the North America closed systems drug transfer devices market in 2019. In terms of end-user, the hospitals and clinics segment accounted for the largest share of the North America closed systems drug transfer devices market in 2019.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the North America closed systems drug transfer devices market report are the World Health Organization (WHO), American Cancer Society (ACS), American Society of Health System Pharmacy (ASHP), and National Cancer Institute (NCI), among others.

Reasons to buy report

• It provides understanding of the North America, closed systems drug transfer devices market landscape and identifies closed systems drug transfer devices market segments that are most likely to guarantee a strong return.
• It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America closed systems drug transfer devices market.
• It helps efficiently plan merger and acquisition, and partnership deals in the closed systems drug transfer devices market by identifying market segments with the most promising probable sales
• It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of closed systems drug transfer devices market performance of various segments pertaining to the North America closed systems drug transfer devices market.
• It provides closed systems drug transfer devices market revenue forecast of the market based on various segments for the period from 2019 to 2027.

NORTH AMERICA CLOSED SYSTEMS DRUG TRANSFER DEVICES MARKET SEGMENTATION

By Closing Mechanism

• Push-to-turn Systems
• Luer-lock Systems
• Color-to-color Alignment Systems
• Click-to-lock Systems

By Type

• Membrane-to-membrane Systems
• Needleless Systems

By Technology

• Diaphragm-based Devices
• Compartmentalized Devices
• Air Cleaning/Filtration Devices

By Component

• Vial Access Devices
• Syringe Safety Devices
• Bag/Line Access Devices
• Accessories

By End User

• Hospitals and Clinics
• Oncology Centers
• Others

By Country

• US
• Canada
• Mexico

Company Profiles

• BD
• B. Braun Medical Inc
• ICU MEDICAL INC
• EQUASHIELD
• Corvida Medical
• Yukon Medical
• Victus, Inc